Key Takeaways from Analyst
The small molecule injectable drugs industry is expected to grow rapidly driven by the increasing prevalence of chronic diseases like cancer and diabetes that boost the demand for small molecule injectable drugs. The demand for chemotherapy drugs, pain management drugs, and anesthetics will see significant growth in the coming years.
Several patent expirations of blockbuster drugs may limit market expansion. However, this will also offer opportunities for generic drug makers. Additionally, the development of advanced drug delivery systems will help boost the small molecule injectable drugs.
North America will likely continue its dominance holding major share of global revenues owing to concentrated presence of prominent manufacturers and availability of advanced healthcare infrastructure. Asia Pacific is anticipated to observe fastest growth in small molecule injectable drugs industry over the forecast period. This can be attributed to growing population, improving access to healthcare facilities and rising healthcare spending in many APAC countries.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients